PTEN and neoplasm: The third tumor suppressor gene therapy candidate is Phosphatase and Tensin Homologue (PTEN) which contains a central catalytic phosphatase core domain that negatively regulates PI3K by dephosphorylating from phosphatidylinositol-triphosphate to phosphatidylinositol-diphosphate [200].